Document is current
Any future updates will be listed below
-
Authors
Vockert, Kim L.
Winter, Natalie
Kirschmann, Friederike S.
Schulz, Jörg B.
Kuhl, Christiane
Nebelung, Sven
Lemainque, Teresa
Dohrn, Maike F. https://orcid.org/0000-0002-5320-9807
-
Funding
Funding for this research was provided by:
RWTH Aachen University
- License Information
-
More Information
Article History
Received: 21 February 2026
Accepted: 12 June 2026
First Online: 23 June 2026
Declarations
:
: The study was conducted in accordance with the Declaration of Helsinki and was approved by the local institutional review board (EK215-18, CTC-A22-338).
: Informed consent was obtained from all subjects involved in the study.
: MFD has received a research grant byPfizer Pharmaceuticals (ASPIRE 2018). She further received financial reimbursement for consulting and advisory board activities and travel support to attend scientific meetings by AkceaTherapeuticals, Alnylam Pharmaceuticals, Applied Therapeutics, Astra Zeneca, Pfizer Pharmaceuticals, and Swedish Orphan Biovitrum AB.NWreceived financial reimbursement for consulting activities and travel support to attend scientific meetings by argenx Germany GmbH, Canon Medical Systems, Pfizer Pharmaceuticals.The remaining authors have no conflicts of interest to disclose.
